HIV Drugs Linked to Lower Alzheimer's Disease Risk, Study Finds

A new study reveals that reverse transcriptase inhibitors, commonly used in HIV treatment, may significantly reduce the incidence of Alzheimer's disease.

Research led by Sanford Burnham Prebys indicates that HIV medications may lower Alzheimer's disease occurrence in older HIV-positive patients.
The study analyzed over 225,000 medical records, finding a lower rate of Alzheimer's among those using reverse transcriptase inhibitors.
This discovery builds on previous research showing similar enzyme activity in Alzheimer's and HIV, suggesting a potential therapeutic overlap.
While preliminary, these findings could lead to repurposing HIV drugs for Alzheimer's, highlighting the need for further clinical trials.
The research was supported by the National Institute on Aging and other foundations, emphasizing its significance and potential impact.